BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 31277414)

  • 1. Mir526b and Mir655 Promote Tumour Associated Angiogenesis and Lymphangiogenesis in Breast Cancer.
    Hunter S; Nault B; Ugwuagbo KC; Maiti S; Majumder M
    Cancers (Basel); 2019 Jul; 11(7):. PubMed ID: 31277414
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chemically Induced Hypoxia Enhances miRNA Functions in Breast Cancer.
    Gervin E; Shin B; Opperman R; Cullen M; Feser R; Maiti S; Majumder M
    Cancers (Basel); 2020 Jul; 12(8):. PubMed ID: 32707933
    [TBL] [Abstract][Full Text] [Related]  

  • 3. miR526b and miR655 Induce Oxidative Stress in Breast Cancer.
    Shin B; Feser R; Nault B; Hunter S; Maiti S; Ugwuagbo KC; Majumder M
    Int J Mol Sci; 2019 Aug; 20(16):. PubMed ID: 31430859
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pri-miR526b and Pri-miR655 Are Potential Blood Biomarkers for Breast Cancer.
    Majumder M; Ugwuagbo KC; Maiti S; Lala PK; Brackstone M
    Cancers (Basel); 2021 Jul; 13(15):. PubMed ID: 34359739
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Breast cancer cell secretome analysis to decipher miRNA regulating the tumor microenvironment and discover potential biomarkers.
    Feser R; Opperman RM; Nault B; Maiti S; Chen VC; Majumder M
    Heliyon; 2023 Apr; 9(4):e15421. PubMed ID: 37128318
    [TBL] [Abstract][Full Text] [Related]  

  • 6. EP4 as a Therapeutic Target for Aggressive Human Breast Cancer.
    Majumder M; Nandi P; Omar A; Ugwuagbo KC; Lala PK
    Int J Mol Sci; 2018 Mar; 19(4):. PubMed ID: 29596308
    [TBL] [Abstract][Full Text] [Related]  

  • 7. PGE2 promotes breast cancer-associated lymphangiogenesis by activation of EP4 receptor on lymphatic endothelial cells.
    Nandi P; Girish GV; Majumder M; Xin X; Tutunea-Fatan E; Lala PK
    BMC Cancer; 2017 Jan; 17(1):11. PubMed ID: 28056899
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The mineral dust-induced gene,
    Zhou H; Geng F; Chen Y; Du J; Zhang X; Liu B; Song D; Hou H; Zhao H
    Oncol Rep; 2021 May; 45(5):. PubMed ID: 33760153
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prostaglandin E2 receptor EP4 as the common target on cancer cells and macrophages to abolish angiogenesis, lymphangiogenesis, metastasis, and stem-like cell functions.
    Majumder M; Xin X; Liu L; Girish GV; Lala PK
    Cancer Sci; 2014 Sep; 105(9):1142-51. PubMed ID: 24981602
    [TBL] [Abstract][Full Text] [Related]  

  • 10. COX-2 induces oncogenic micro RNA miR655 in human breast cancer.
    Majumder M; Dunn L; Liu L; Hasan A; Vincent K; Brackstone M; Hess D; Lala PK
    Sci Rep; 2018 Jan; 8(1):327. PubMed ID: 29321644
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Targeting COX-2 and EP4 to control tumor growth, angiogenesis, lymphangiogenesis and metastasis to the lungs and lymph nodes in a breast cancer model.
    Xin X; Majumder M; Girish GV; Mohindra V; Maruyama T; Lala PK
    Lab Invest; 2012 Aug; 92(8):1115-28. PubMed ID: 22641101
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Roles of prostaglandins in tumor-associated lymphangiogenesis with special reference to breast cancer.
    Lala PK; Nandi P; Majumder M
    Cancer Metastasis Rev; 2018 Sep; 37(2-3):369-384. PubMed ID: 29858743
    [TBL] [Abstract][Full Text] [Related]  

  • 13. microRNA-128 plays a critical role in human non-small cell lung cancer tumourigenesis, angiogenesis and lymphangiogenesis by directly targeting vascular endothelial growth factor-C.
    Hu J; Cheng Y; Li Y; Jin Z; Pan Y; Liu G; Fu S; Zhang Y; Feng K; Feng Y
    Eur J Cancer; 2014 Sep; 50(13):2336-50. PubMed ID: 25001183
    [TBL] [Abstract][Full Text] [Related]  

  • 14. COX-2 Elevates Oncogenic miR-526b in Breast Cancer by EP4 Activation.
    Majumder M; Landman E; Liu L; Hess D; Lala PK
    Mol Cancer Res; 2015 Jun; 13(6):1022-33. PubMed ID: 25733698
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of molecular determinants of angiogenesis and lymphangiogenesis in lymph node metastases and in primary tumours of patients with breast cancer.
    Van den Eynden GG; Van der Auwera I; Van Laere SJ; Trinh XB; Colpaert CG; van Dam P; Dirix LY; Vermeulen PB; Van Marck EA
    J Pathol; 2007 Sep; 213(1):56-64. PubMed ID: 17674348
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression and localization of locally produced growth factors regulating lymphangiogenesis during different stages of the estrous cycle in corpus luteum of buffalo (Bubalus bubalis).
    Ali I; Chouhan VS; Dangi SS; Gupta M; Tandiya U; Hyder I; Yadav VP; Panda RP; Babitha V; Nagar V; Sonwane A; Khan FA; Das BC; Singh G; Bag S; Sarkar M
    Theriogenology; 2014 Feb; 81(3):428-36. PubMed ID: 24246422
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adipose-Derived Stem Cells Improve Angiogenesis and Lymphangiogenesis in a Hypoxic Dermal Regeneration Model In Vitro.
    Fuchs B; Birt A; Moellhoff N; Kuhlmann C; Giunta RE; Wiggenhauser PS
    Medicina (Kaunas); 2023 Apr; 59(4):. PubMed ID: 37109664
    [No Abstract]   [Full Text] [Related]  

  • 18. Vegfd modulates both angiogenesis and lymphangiogenesis during zebrafish embryonic development.
    Bower NI; Vogrin AJ; Le Guen L; Chen H; Stacker SA; Achen MG; Hogan BM
    Development; 2017 Feb; 144(3):507-518. PubMed ID: 28087639
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dual blockade of VEGFR1 and VEGFR2 by a novel peptide abrogates VEGF-driven angiogenesis, tumor growth, and metastasis through PI3K/AKT and MAPK/ERK1/2 pathway.
    Sadremomtaz A; Mansouri K; Alemzadeh G; Safa M; Rastaghi AE; Asghari SM
    Biochim Biophys Acta Gen Subj; 2018 Dec; 1862(12):2688-2700. PubMed ID: 30251659
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prostaglandin E2 Receptor 4 (EP4) as a Therapeutic Target to Impede Breast Cancer-Associated Angiogenesis and Lymphangiogenesis.
    De Paz Linares GA; Opperman RM; Majumder M; Lala PK
    Cancers (Basel); 2021 Feb; 13(5):. PubMed ID: 33668160
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.